It is unknown if bioidentical micronized progesterone would increase breast cancer risk similarly to MPA, although some observational studies suggest a lesser increase.

“the question has been raised with other types of progestogens such as the bioidentical micronized progesterone would that also lead to an increased risk of breast cancer there are some observational studies that suggest less increase in breast cancer with that particular formulation of a progestogen”